Nootropics
Evidence: moderate_human
Beta-phenyl derivative of GABA that crosses the blood-brain barrier (unlike GABA itself) due to the addition of a phenyl ring. Acts as a full agonist at GABA-B receptors with 30-68x lower affinity than baclofen, requiring correspondingly higher doses. Also binds to and blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (VDCCs), making it a gabapentinoid similar to gabapentin and pregabalin. At low concentrations, mildly increases dopamine levels in the brain, providing stimulatory and nootropic effects alongside anxiolysis. Weak agonist activity at GABA-A receptors at higher doses.
Standard: 250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk)
Administration: oral
Timing: On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours.
Duration: STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence.
FOR EDUCATIONAL PURPOSES ONLY. Phenibut is one of the most dangerous nootropics due to its rapid tolerance development and severe withdrawal syndrome. Originally developed in Russia in the 1960s and reportedly included in Soviet cosmonaut medical kits. The nootropic effects (improved cognition under stress, anxiolysis without sedation) occur at lower doses, but the anxiolytic effects that most users seek require doses where tolerance quickly develops. Withdrawal can be life-threatening and may include seizures, psychosis, and hallucinations — comparable to benzodiazepine or alcohol withdrawal. Tapering under medical supervision is recommended for dependent users. Baclofen is sometimes used to manage phenibut withdrawal due to shared GABA-B mechanism. This compound should NEVER be used daily. The risk-benefit ratio is poor for most users given the availability of safer anxiolytics.
Available as a dietary supplement in some countries (notably the US) despite growing regulatory scrutiny. Banned or controlled in Australia, Hungary, and several other countries. Available as both HCl salt and free amino acid (FAA) form — HCl is more common and acidic, FAA is less irritating. Source with CoA from established vendors. Pharmaceutical-grade exists in Russia/former Soviet states where it is approved as an anxiolytic.
Take the free assessment and get personalized recommendations based on your biology and goals.
Get Your Free Protocolor take the assessment →